These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 22030709)

  • 1. Gray matter volumes in obsessive-compulsive disorder before and after fluoxetine or cognitive-behavior therapy: a randomized clinical trial.
    Hoexter MQ; de Souza Duran FL; D'Alcante CC; Dougherty DD; Shavitt RG; Lopes AC; Diniz JB; Deckersbach T; Batistuzzo MC; Bressan RA; Miguel EC; Busatto GF
    Neuropsychopharmacology; 2012 Feb; 37(3):734-45. PubMed ID: 22030709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential prefrontal gray matter correlates of treatment response to fluoxetine or cognitive-behavioral therapy in obsessive-compulsive disorder.
    Hoexter MQ; Dougherty DD; Shavitt RG; D'Alcante CC; Duran FL; Lopes AC; Diniz JB; Batistuzzo MC; Evans KC; Bressan RA; Busatto GF; Miguel EC
    Eur Neuropsychopharmacol; 2013 Jul; 23(7):569-80. PubMed ID: 22841131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cortico-striato-thalamo-cortical circuit abnormalities in obsessive-compulsive disorder: A voxel-based morphometric and fMRI study of the whole brain.
    Tang W; Zhu Q; Gong X; Zhu C; Wang Y; Chen S
    Behav Brain Res; 2016 Oct; 313():17-22. PubMed ID: 27388149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regional gray matter abnormalities in obsessive-compulsive disorder: a voxel-based morphometry study.
    Valente AA; Miguel EC; Castro CC; Amaro E; Duran FL; Buchpiguel CA; Chitnis X; McGuire PK; Busatto GF
    Biol Psychiatry; 2005 Sep; 58(6):479-87. PubMed ID: 15978549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Caudate volume differences among treatment responders, non-responders and controls in children with obsessive-compulsive disorder.
    Vattimo EFQ; Barros VB; Requena G; Sato JR; Fatori D; Miguel EC; Shavitt RG; Hoexter MQ; Batistuzzo MC
    Eur Child Adolesc Psychiatry; 2019 Dec; 28(12):1607-1617. PubMed ID: 30972581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. White matter structural alterations in pediatric obsessive-compulsive disorder: relation to symptom dimensions.
    Lázaro L; Ortiz AG; Calvo A; Ortiz AE; Moreno E; Morer A; Calvo R; Bargallo N
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Oct; 54():249-58. PubMed ID: 24977330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased orbital frontal gray matter volume after cognitive behavioural therapy in paediatric obsessive compulsive disorder.
    Huyser C; van den Heuvel OA; Wolters LH; de Haan E; Boer F; Veltman DJ
    World J Biol Psychiatry; 2013 May; 14(4):319-31. PubMed ID: 22746998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The drug-naïve OCD patients imaging genetics, cognitive and treatment response study: methods and sample description.
    Hoexter MQ; Shavitt RG; D'Alcante CC; Cecconi JP; Diniz JB; Belotto-Silva C; Hounie AG; Borcato S; Moraes I; Joaquim MA; Cappi C; Sampaio AS; Mathis MA; Batistuzzo MC; Lopes AC; Rosa AC; Muniz RK; Marques AH; Santos LC; Taub A; Duran FL; Dougherty DD; Busatto GF; Bressan RA; Miguel EC
    Braz J Psychiatry; 2009 Dec; 31(4):349-53. PubMed ID: 20098825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Addition of cognitive-behaviour therapy for obsessive-compulsive disorder patients non-responding to fluoxetine.
    Kampman M; Keijsers GP; Hoogduin CA; Verbraak MJ
    Acta Psychiatr Scand; 2002 Oct; 106(4):314-9. PubMed ID: 12225499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morphometric brain characterization of refractory obsessive-compulsive disorder: diffeomorphic anatomic registration using exponentiated Lie algebra.
    Tang W; Li B; Huang X; Jiang X; Li F; Wang L; Chen T; Wang J; Gong Q; Yang Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Oct; 46():126-31. PubMed ID: 23876787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical predictors of long-term outcome in obsessive-compulsive disorder.
    Jakubovski E; Diniz JB; Valerio C; Fossaluza V; Belotto-Silva C; Gorenstein C; Miguel E; Shavitt RG
    Depress Anxiety; 2013 Aug; 30(8):763-72. PubMed ID: 23109056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gray matter differences between pediatric obsessive-compulsive disorder patients and high-risk siblings: a preliminary voxel-based morphometry study.
    Gilbert AR; Keshavan MS; Diwadkar V; Nutche J; Macmaster F; Easter PC; Buhagiar CJ; Rosenberg DR
    Neurosci Lett; 2008 Apr; 435(1):45-50. PubMed ID: 18314272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural brain abnormalities correlate with clinical features in patients with drug-naïve OCD: A DARTEL-enhanced voxel-based morphometry study.
    Tang W; Huang X; Li B; Jiang X; Li F; Xu J; Yang Y; Gong Q
    Behav Brain Res; 2015 Nov; 294():72-80. PubMed ID: 26241173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive-behavioral therapy as an adjunct to serotonin reuptake inhibitors in obsessive-compulsive disorder: an open trial.
    Simpson HB; Gorfinkle KS; Liebowitz MR
    J Clin Psychiatry; 1999 Sep; 60(9):584-90. PubMed ID: 10520976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of combination of fluoxetine and cognitive behavioral therapy and fluoxetine alone for the treatment of obsessive compulsive disorder.
    Giasuddin NA; Nahar JS; Morshed NM; Balhara YP; Sobhan MA
    Pak J Pharm Sci; 2013 Jan; 26(1):95-8. PubMed ID: 23261733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of cognitive behavioral therapy on resting-state functional brain network in drug-naive patients with obsessive-compulsive disorder.
    Li P; Yang X; Greenshaw AJ; Li S; Luo J; Han H; Liu J; Zhong Z; Guo Z; Xiong H; Yao S; Chen Y; Sun J; Li Z
    Brain Behav; 2018 May; 8(5):e00963. PubMed ID: 29761016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Addition of cognitive-behavioral therapy for nonresponders to medication for obsessive-compulsive disorder: a naturalistic study.
    Tundo A; Salvati L; Busto G; Di Spigno D; Falcini R
    J Clin Psychiatry; 2007 Oct; 68(10):1552-6. PubMed ID: 17960971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gray matter structural alterations in psychotropic drug-naive pediatric obsessive-compulsive disorder: an optimized voxel-based morphometry study.
    Szeszko PR; Christian C; Macmaster F; Lencz T; Mirza Y; Taormina SP; Easter P; Rose M; Michalopoulou GA; Rosenberg DR
    Am J Psychiatry; 2008 Oct; 165(10):1299-307. PubMed ID: 18413702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Widespread structural brain changes in OCD: a systematic review of voxel-based morphometry studies.
    Piras F; Piras F; Chiapponi C; Girardi P; Caltagirone C; Spalletta G
    Cortex; 2015 Jan; 62():89-108. PubMed ID: 23582297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological heterogeneity of obsessive-compulsive disorder: A voxel-based morphometric study based on dimensional assessment.
    Okada K; Nakao T; Sanematsu H; Murayama K; Honda S; Tomita M; Togao O; Yoshiura T; Kanba S
    Psychiatry Clin Neurosci; 2015 Jul; 69(7):411-21. PubMed ID: 25556718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.